Published in Crit Care Med on June 01, 1992
Statins for the Early Treatment of Sepsis (SETS) | NCT00528580
Hydrocortisone for Prevention of Septic Shock (HYPRESS) | NCT00670254
Comparison of Vasopressin and Other Pressors in Septic Shock | NCT00269685
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA (2016) 17.49
The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis (2010) 7.07
Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med (2007) 5.65
Sepsis definitions: time for change. Lancet (2013) 5.63
Intensity of rainfall and severity of melioidosis, Australia. Emerg Infect Dis (2003) 3.41
Atrial Fibrillation Is an Independent Predictor of Mortality in Critically Ill Patients. Crit Care Med (2015) 2.77
Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med (2008) 2.64
Brazilian Sepsis Epidemiological Study (BASES study). Crit Care (2004) 2.49
Sepsis: definition, epidemiology, and diagnosis. BMJ (2007) 2.43
Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ (2004) 2.39
Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness. Shock (2007) 2.37
Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease. Chest (2007) 2.34
Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther (2012) 2.34
PCSK9 is a critical regulator of the innate immune response and septic shock outcome. Sci Transl Med (2014) 2.33
Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study. Crit Care (2009) 2.32
Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care (2004) 2.30
Severe sepsis epidemiology: sampling, selection, and society. Crit Care (2004) 2.28
Epidemiology of severe sepsis. Virulence (2013) 2.26
The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis. Crit Care Med (2004) 2.24
Fluid balance and acute kidney injury. Nat Rev Nephrol (2009) 2.23
Applying dynamic parameters to predict hemodynamic response to volume expansion in spontaneously breathing patients with septic shock. Shock (2013) 2.14
The value of Modified Early Warning Score (MEWS) in surgical in-patients: a prospective observational study. Ann R Coll Surg Engl (2006) 2.11
Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol (2009) 2.03
Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother (2004) 2.02
Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease. Intensive Care Med (2010) 2.00
The burden of sepsis-associated mortality in the United States from 1999 to 2005: an analysis of multiple-cause-of-death data. Crit Care (2009) 1.99
The Italian SEPSIS study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med (1995) 1.99
VTE Incidence and Risk Factors in Patients With Severe Sepsis and Septic Shock. Chest (2015) 1.99
Delirium in older emergency department patients: recognition, risk factors, and psychomotor subtypes. Acad Emerg Med (2009) 1.95
Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care (2009) 1.93
Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis. Crit Care (2013) 1.88
Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am J Respir Cell Mol Biol (2006) 1.88
Isolates of Burkholderia pseudomallei from Northern Australia are distinct by multilocus sequence typing, but strain types do not correlate with clinical presentation. J Clin Microbiol (2004) 1.88
Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases. Eur J Clin Microbiol Infect Dis (2003) 1.87
Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial. Crit Care (2009) 1.87
Diastolic dysfunction and mortality in severe sepsis and septic shock. Eur Heart J (2011) 1.86
Admission angiopoietin levels in children with septic shock. Shock (2007) 1.82
Temporal disorganization of circadian rhythmicity and sleep-wake regulation in mechanically ventilated patients receiving continuous intravenous sedation. Sleep (2012) 1.82
Evaluation of pathogen detection from clinical samples by real-time polymerase chain reaction using a sepsis pathogen DNA detection kit. Crit Care (2010) 1.81
The Shock Index revisited - a fast guide to transfusion requirement? A retrospective analysis on 21,853 patients derived from the TraumaRegister DGU. Crit Care (2013) 1.77
Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality. Intensive Care Med (2010) 1.75
Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect Immun (2003) 1.75
The association between BMI and plasma cytokine levels in patients with acute lung injury. Chest (2010) 1.75
The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis. Crit Care (2010) 1.72
Strategies to reduce mortality from bacterial sepsis in adults in developing countries. PLoS Med (2008) 1.70
Characteristics and outcomes of cancer patients in European ICUs. Crit Care (2009) 1.70
Hypertonic saline up-regulates A3 adenosine receptor expression of activated neutrophils and increases acute lung injury after sepsis. Crit Care Med (2008) 1.66
Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun (1998) 1.64
Early acute lung injury: criteria for identifying lung injury prior to the need for positive pressure ventilation*. Crit Care Med (2013) 1.62
Serum levels of osteopontin are increased in SIRS and sepsis. Intensive Care Med (2008) 1.58
Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infect Immun (2000) 1.58
Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study. Crit Care (2010) 1.56
Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care (2002) 1.55
Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol (2009) 1.55
Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases. Antimicrob Agents Chemother (2005) 1.55
The influence of N-acetyl-L-cystein infusion on cytokine levels and gastric intramucosal pH during severe sepsis. Crit Care (2004) 1.54
Risk factors for urosepsis following percutaneous nephrolithotomy: role of 1 week of nitrofurantoin in reducing the risk of urosepsis. Urol Res (2011) 1.53
The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia. Thorax (2006) 1.53
Differences in critical care practice between an industrialized and a developing country. Wien Klin Wochenschr (2008) 1.52
Severe acute pancreatitis: pathogenetic aspects and prognostic factors. World J Gastroenterol (2008) 1.51
StO₂ guided early resuscitation in subjects with severe sepsis or septic shock: a pilot randomised trial. J Clin Monit Comput (2013) 1.51
Acute loss of renal function attenuates slow leukocyte rolling and transmigration by interfering with intracellular signaling. Kidney Int (2011) 1.51
Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care (2005) 1.49
Biomarkers of sepsis. Crit Rev Clin Lab Sci (2013) 1.48
Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma. Crit Care (2010) 1.48
Outcomes of patients with melioidosis treated with meropenem. Antimicrob Agents Chemother (2004) 1.48
Plasma granulocyte colony-stimulating factor levels correlate with clinical outcomes in patients with acute lung injury. Crit Care Med (2009) 1.47
Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit Care (2003) 1.46
The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study. Crit Care (2013) 1.46
Pre-validation of the WHO organ dysfunction based criteria for identification of maternal near miss. Reprod Health (2011) 1.45
Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins. J Clin Invest (2001) 1.44
Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shock. J Inflamm (Lond) (2010) 1.44
Delirium risk stratification in consecutive unselected admissions to acute medicine: validation of externally derived risk scores. Age Ageing (2016) 1.43
Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically Ill trauma patients: early results of a randomized controlled trial. World J Surg (2006) 1.42
Lipopolysaccharide Is Cleared from the Circulation by Hepatocytes via the Low Density Lipoprotein Receptor. PLoS One (2016) 1.42
Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock. Mayo Clin Proc (2012) 1.40
Hemostasis during the early stages of trauma: comparison with disseminated intravascular coagulation. Crit Care (2014) 1.40
The impact of Hispanic ethnicity and race on post-surgical complications in patients with inflammatory bowel disease. Dig Dis Sci (2013) 1.40
Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Crit Care (2004) 1.37
Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. CMAJ (2005) 1.36
Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg (2008) 1.35
Gene expression profiles differentiate between sterile SIRS and early sepsis. Ann Surg (2007) 1.35
Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2). J Lipid Res (2010) 1.35
Treatment of high-output enterocutaneous fistulas with a vacuum-compaction device. A ten-year experience. World J Surg (2008) 1.34
Comparison between logistic regression and neural networks to predict death in patients with suspected sepsis in the emergency room. Crit Care (2005) 1.34
The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability. Crit Care (2008) 1.34
A prospective observational study of the relationship of critical illness associated hyperglycaemia in medical ICU patients and subsequent development of type 2 diabetes. Crit Care (2010) 1.33
Prevalence and incidence of severe sepsis in Dutch intensive care units. Crit Care (2004) 1.33
Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. Crit Care (2008) 1.32
C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study. Crit Care (2011) 1.31
Sepsis: Something old, something new, and a systems view. J Crit Care (2011) 1.29
Active cytomegalovirus infection in patients with septic shock. Emerg Infect Dis (2006) 1.28
Higher vs. lower fluid volume for septic shock: clinical characteristics and outcome in unselected patients in a prospective, multicenter cohort. Crit Care (2012) 1.28
Elevated levels of plasma mitochondrial DNA DAMPs are linked to clinical outcome in severely injured human subjects. Ann Surg (2013) 1.27
Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. Crit Care (2014) 1.26
Adjuvant selenium supplementation in the form of sodium selenite in postoperative critically ill patients with severe sepsis. Crit Care (2014) 1.26
Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis. Crit Care (2011) 1.26